Search
for
Sort by
Research 301–330 of 1000+
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- A phase 2a trial of brepocitinib for cicatricial alopecia
- The Wound Reporting in Animal and Human Preclinical Studies (WRAHPS) Guidelines
- Potential of Colostrum-Derived Exosomes for Promoting Hair Regeneration Through the Transition From Telogen to Anagen Phase
- Glycogen phase separation drives macromolecular rearrangement and asymmetric division in E. coli
- Effect of Neurosteroids on Basal and Stress-Induced Oxytocin Secretion in Luteal-Phase and Pregnant Sheep
- Critical Appraisal of Reports on the Treatment of Perioral Dermatitis
- Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
- The Type I Keratin 19 Possesses Distinct and Context-dependent Assembly Properties
- Histopathology of alopecia areata, acute and chronic: Why is it important to the clinician?
- THE ENDOCRINE SYSTEM AND HAIR GROWTH IN THE RAT
- Synergistic effects of mesenchymal stem cells and their secretomes with scaffolds in burn wound healing: a systematic review and meta-analysis of preclinical studies
- Androgenetic alopecia (male pattern hair loss) in the United States: What treatments should primary care providers recommend?
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Cytostatics and immunosuppressive drugs
- Development of phage-containing hydrogel for treating Enterococcus faecalis-infected wounds
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Human Peptidylarginine Deiminase Type III: Molecular Cloning and Nucleotide Sequence of the cDNA, Properties of the Recombinant Enzyme, and Immunohistochemical Localization in Human Skin
- Gene Array Profiling and Immunomodulation Studies Define a Cell-Mediated Immune Response Underlying the Pathogenesis of Alopecia Areata in a Mouse Model and Humans
- Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil®, Finasteride®, and Adult Stem Cell-Based Therapy
- WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH
- Association between metabolic syndrome and prevalent skin diseases: A systematic review and meta‐analysis of case‐control studies
- Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review
- Chemical Constituents & Therapeutic Uses of Eclipta Prostrata Linn
- Modern Approaches to Treatment of Alopecia X in Dogs: Review of Research
- A Bio‐Functional Wnt3a Gradient Microarray for Cell Niche Studies
- Faculty Opinions recommendation of Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial.